SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-008376
Filing Date
2021-02-25
Accepted
2021-02-25 06:00:47
Documents
14
Period of Report
2021-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amrn-8k_20210225.htm   iXBRL 8-K 38994
2 EX-99.1 amrn-ex991_6.htm EX-99.1 577272
3 GRAPHIC gj1qt52v1hoj000001.jpg GRAPHIC 18327
  Complete submission text file 0001564590-21-008376.txt   809324

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA amrn-20210225.xsd EX-101.SCH 5784
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20210225_lab.xml EX-101.LAB 20166
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20210225_pre.xml EX-101.PRE 12071
7 EXTRACTED XBRL INSTANCE DOCUMENT amrn-8k_20210225_htm.xml XML 3778
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21392 | Film No.: 21676226
SIC: 2834 Pharmaceutical Preparations